Outcome after first relapse in childhood acute lymphoblastic leukaemia - lessons from the United Kingdom R2 trial.
第一作者:
Anindita,Roy
第一单位:
Cancer Research UK Children's Cancer Group, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
作者:
医学主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);天冬酰胺酶(Asparaginase);骨髓移植(Bone Marrow Transplantation);儿童(Child);综合疗法(Combined Modality Therapy);无病生存(Disease-Free Survival);表柔比星(Epirubicin);女(雌)性(Female);人类(Humans);男(雄)性(Male);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);泼尼松龙(Prednisolone);复发(Recurrence);缓解诱导(Remission Induction);回顾性研究(Retrospective Studies);危险因素(Risk Factors);存活率(Survival Rate);治疗结果(Treatment Outcome);长春新碱(Vincristine)
DOI
10.1111/j.1365-2141.2005.05572.x
PMID
15982346
发布时间
2025-05-29
- 浏览23
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



